Course Overview

BUS-441: Contemporary Pharmacoeconomics (3 Credits)
Program(s): CMR and CPM

COURSE CONSULTANTS

THIRD AND FOURTH EDITIONS

J. Lyle Bootman, PhD
Dean, College of PharmacyProfessor of Pharmacy, Medicine, and Public Health

Executive Director of the Center for Health Outcomes and Pharmacoeconomic (HOPE) Research
Arizona Health Sciences Center
The University of Arizona
Tucson, Arizona

C.E. (Gene) Reeder, PhD
Professor of Pharmacoeconomics
College of Pharmacy
University of South Carolina
Columbia, South Carolina

Graduate Supplement
BUS-5441
To earn graduate-level credit, BUS-441 and an additional supplement must be successfully completed.

Click here for more information about graduate-level credit.

Who Should Take This Course:
Managers, sales representatives, and others who interact with those
healthcare professionals, including physicians, pharmacists, and administrators, who regularly use pharmacoeconomic data or who design and conduct pharmacoeconomic studies.

Career Applications/Benefits:
With the current focus on demonstrating the value of pharmaceutical products, the science of pharmacoeconomics has gained increasing importance in the decision processes by which healthcare organizations and prescribers select drug therapies. In fact, many regulatory authorities around the world require pharmacoeconomic data at the time of drug approval. Pharmacoeconomic analyses and models described in this course can help demonstrate the value of pharmaceutical products to physicians and pharmacists interested in evidence-based decision making. This course will be of particular benefit to those who interact with managed care organizations, which are focused on ways to provide healthcare as efficiently as possible. The course also has value to anyone involved in the process of obtaining formulary approval for pharmaceutical products.

Course Description:
This course provides a basic understanding of the science of pharmacoeconomics. It describes the primary methods of pharmacoeconomic analysis and uses case studies to illustrate their applications in healthcare. The course also discusses how pharmacoeconomic data can be used to help gain formulary approval for pharmaceutical products.

Related Courses:

The 21st Century Physician
The Managed Healthcare Market
Applications of Evidence-Based Medicine
Outcomes: Measurement, Management, and Marketing
The Formulary Process—Managing the Pharmacy Benefit
The Value of Pharmaceuticals

Chapter Content:

Chapter 1: The Context of Pharmacoeconomics
	Rationale for Pharmacoeconomic Analyses Components of Outcomes Research and Management Benefits of Pharmacoeconomic Research
Chapter 2: Components of Pharmacoeconomic Research
	Basic Structure of a Pharmacoeconomic Study Identifying Costs Identifying Consequences Evaluating Pharmacoeconomic Data
Chapter 3: Review of Pharmacoeconomic Methods
	Cost-Benefit Analysis (CBA) Cost-Effectiveness Analysis (CEA) Cost-Minimization Analysis (CMA) Cost-Utility Analysis (CUA) Significance of Pharmacoeconomic Analyses
Chapter 4: Case Study Review of Key Pharmacoeconomic Models
	Case Study 1: A Cost-Minimization Analysis to Evaluate Statins for Maintenance Therapy Case Study 2: Cost-Effectiveness of Aspirin Versus Alternatives to Prevent Recurrent Ischemic Stroke Case Study 3: Implications of Controlling for Comorbid Conditions in Cost-of-Illness Estimates: A Case Study of Osteoarthritis from a Managed Care System Perspective Case Study 4: Changes in Resource Use and Outcomes for Patients with Migraine Treated with Serotonin (5-HT) Receptor Agonist Case Study 5: Cost-Effectiveness of Product A Compared to Product B in the Treatment of Parkinson Disease
Chapter 5: Impact of Pharmacoeconomics
	Impact of Pharmacoeconomics on the Formulary Trends Influencing Pharmacoeconomic Research

Learning Objectives:
Upon successful completion of this course, the student will be able to discuss the impact of pharmacoeconomics on hospitals, physicians, patients, and society at large; describe the basic structure of a pharmacoeconomic study; and describe and apply the pharmacoeconomic methods of cost-benefit analysis, cost-effectiveness analysis, cost-minimization analysis, and cost-utility analysis.